Dosimetric Comparison Between 2-Dimensional Radiation Therapy and Intensity Modulated Radiation Therapy in Treatment of Advanced T-Stage Nasopharyngeal Carcinoma: To Treat Less or More in the Planning Organ-At-Risk Volume of the Brainstem and Spinal Cord

Medical Dosimetry

Volumn 32, Issue 4, 2007, Pages 263-270

  Chau, Ricky M C ^a   Teo, Peter M L ^b   Kam, Michael K M ^a   Leung, S F ^a   Cheung, K Y ^a   Chan, Anthony T C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Department of Clinical Oncology   (Hong Kong)

Author keywords

2DRT; Advanced T stage; DVH; IMRT; NPC; NTCP; TCP

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; BRAIN STEM; CALCULATION; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DOSIMETRY; HISTOGRAM; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; NASOPHARYNX CARCINOMA; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; SIMULATION; SPINAL CORD; TARGET ORGAN; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

BRAIN STEM; HUMANS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; SPINAL CORD;

EID: 35548996363     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meddos.2007.02.006     Document Type: Article

References (30)

1. Ho J.H.C. Nasopharynx. In: Halnan K.E. (Ed). Treatment of Cancer (1982), Chapman and Hall, London 24-68
2. Ho J. An epidemiological and clinical study of nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 4 (1978) 183-205
3. Teo P.M., Tsao S.Y., Shiu W., et al. A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong. Int. J. Radiat. Oncol. Biol. Phys. 17 (1989) 515-530
4. Lee A.W., Poon Y., Foo W., et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: Overall survival and patterns of failure. Int. J. Radiat. Oncol. Biol. Phys. 23 (1992) 261-270
5. Teo P.M.L., Yu P., Lee W.Y., et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int. J. Radiat. Oncol. Biol. Phys. 36 (1996) 291-304
6. Lee A.W.M., Sze W.M., Joseph S.K., et al. Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong Experience. Int. J. Radiat. Oncol. Biol. Phys. 61 (2005) 1107-1116
7. Kam M.K.M., Chau R.M.C., Suen J., et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: Dosimetric advantage over conventional plans and feasibility of dose escalation. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 145-157
8. Hunt M.A., Zelefsky M., Wolden S., et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int. J. Radiat. Oncol. Biol. Phys. 49 (2001) 623-632
9. Zhou J., Fei D., and Wu Q. Potential of intensity-modulated radiotherapy to escalate doses to head-and-neck cancers: What is the maximal dose?. Int. J. Radiat. Oncol. Biol. Phys. 57 (2003) 673-682
10. Sultanem K., Shu H.K., Xia P., et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The University of California-San Francisco experience. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 711-722
11. ICRU Report 62. Prescribing, Recording, and Reporting Photon Beam Therapy. Supplement to ICRU Report 50 (1999), ICRU, Bethesda
12. Cheng J.C., and Low D. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int. J. Cancer 96 (2001) 126-131
13. Lee N., Xia P., Quivery J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 12-22
14. Xia P., Fu K., Wong G.W., et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 329-337
15. Chao K.S., Perez C.A., and Purdy J.A. Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience. Int. J. Cancer 90 (2000) 92-103
16. Chau R.M., Teo P.M., Choi P.H.K., et al. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma. Radiother. Oncol. 58 (2001) 143-153
17. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 5th ed. (1997), UICC, Geneva
18. Wong S.M. The use of anchoring bite system in NPC treatment setup. J. H.K. Coll. Radiol. Suppl. 6 (2003) 127
19. Niemierko A., and Goitein M. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother. Oncol. 29 (1993) 140-147
20. Webb S., and Nahum A.E. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and colongenic cell density. Phys. Med. Biol. 38 (1993) 653-666
21. Burman C., Kutcher G.J., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int. J. Radiat. Oncol. Biol. Phys. 21 (1991) 123-135
22. Lyman J.T., and Wolbarst A.B. Optimization of radiation therapy, III: A method of assessing complication probability from dose-volume histograms. Int. J. Radiat. Oncol. Biol. Phys. 13 (1987) 103-109
23. Sanchez-Nieto B., and Nahum A.E. The Delta Concept: A clinically useful measure of tumor control probabilty. Int. J. Radiat. Oncol. Biol. Phys. 44 (1999) 369-380
24. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic radiation. Int. J. Radiat. Oncol. Biol. Phys. 16 (1991) 1623-1630
25. Raaijmakers E., and Engelen A. Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation?. A systematic review of the literature. Radiother. Oncol. 65 (2002) 1-7
26. Honore H.B., Moller K., and Grau C. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: Individualized risk-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 638-647
27. Eisbruch A., Ten Haken R., Kim H.M., et al. Dose, volume and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 45 (1999) 577-587
28. Chao K.S., Deasey J., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int. J. Radiat. Oncol. Biol. Phys. 49 (2001) 907-915
29. Kam M.K.M., Teo P.M.L., Chau R.M.C., et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong Experience. Int. J. Radiat. Oncol. Biol. Phys. 60 (2004) 1440-1450
30. Purdy J. Dose-volume specification: New challenges with intensity modulated radiation therapy. Semin. Radiat. Oncol. 12 (2002) 199-209